| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0004 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |